GSK in talks to acquire Nuvalent for over $9 billion in largest deal in more than a decade
By
Anniek Bao
Crackling crust, pillowy middle. The kind of bagel that earns a second cup of coffee.
Summary
GSK is in talks to acquire biotech firm Nuvalent for more than $9 billion, which would be its largest acquisition in over a decade and the second largest in its history, trailing only its 2014 asset swap with Novartis. The deal marks a shift from GSK's recent focus on smaller transactions in the £2-4 billion range, as CEO Luke Miels pursues larger M&A. The acquisition comes amid a biotech dealmaking frenzy driven by patent cliffs, buoyant public markets, and drugmakers' need to strengthen their pipelines.
Key quotes
· 3 pulledThe deal would be the second largest acquisition in GSK's history, the FT reported, trailing its 2014 asset swap with Novartis in which it assumed control of the Swiss drugmaker's vaccines division in a transaction valued at $20 billion.
It would also mark a notable departure from the company's focus on smaller transactions in recent years.
GSK chief executive Luke Miels, who took over the job from longtime boss Emma Walmsley at the start of the year, told investors in February that he would focus on transactions in the £2 billion to £4 billion range
You might also wanna read

Nvidia Acquires AI Chip Startup Groq's Assets in $20 Billion Deal
Nvidia is acquiring assets from AI chip startup Groq for approximately $20 billion in cash, marking Nvidia's largest acquisition to date. Th
Groq reportedly raising $650M despite Nvidia licensing its technology and hiring key staff
Groq, the AI chip company that was thought to have been acquired by Nvidia in December 2024, is reportedly raising $650M. However, Nvidia on
Amgen's PCSK9 Patent Battle: Legal Loss but Commercial Victory
This article examines Amgen's legal battle over PCSK9 cholesterol drugs, specifically their patent dispute with Sanofi and Regeneron. Amgen

SpaceX Announces Potential $60 Billion Acquisition of AI Programming Platform Cursor
SpaceX has announced an unusual arrangement to potentially acquire Cursor, an automated AI programming platform, for $60 billion later this

Private Equity Firm Goldenpeak Acquires Ampere Analysis, Which Also Buys PlumResearch
Private equity firm Goldenpeak has acquired Ampere Analysis, the UK-based entertainment analytics firm, marking its first deal since launchi
Nvidia Acquires $5 Billion Stake in Intel Under September Agreement
Nvidia has acquired a $5 billion stake in Intel, according to a regulatory filing on Monday. The transaction was part of an agreement announ
